C12N 2760/20242
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2760/20242 (Virus or viral particle as vehicle) appears on 4 US grants and 15 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 15
- Assignees
- 14
- Inventors
- 39
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 2 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 4 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Coronavirus pseudovirus packaging system, packaging method therefor, and application of coronavirus pseudovirus in evaluating disinfection efficacy14 Apr 2026US 12,600,988 B2Fantasia Biopharma (Zhejiang) Co. Ltd
- Vaccine composition26 May 2020US 10,660,947 B2Turnstone Limited Partnership
- Vaccine composition12 May 2020US 10,646,557 B2Turnstone Limited Partnership
- Vaccine composition30 Jul 2019US 10,363,293 B2Turnstone Limited Partnership
- Arrdc1-mediated microvesicle-based delivery of therapeutic agents to cells of the peripheral nervous system27 Aug 2026US 2026/0248957 A1Turn Biotechnologies, Inc.
- Modified rhabdovirus glycoproteins and uses thereof6 Nov 2025US 2025/0339384 A1Regeneron Pharmaceuticals, Inc.
- Tissue and cell-type specific delivery of therapeutic molecules incorporating viral and human fusiogenic proteins5 Jun 2025US 2025/0177555 A1The Regents of the University of Colorado, a body corporate
- Versatile virus-like-vesicles (vlv) platform for infectious diseases and cancer immunotherapy applications5 Dec 2024US 2024/0398921 A1Carogen Corporation
- Self-replicating rna molecules and application thereof5 Dec 2024US 2024/0401076 A1
Most cited
By later US patents